化学优化的逻辑

IF 6.8 1区 医学 Q1 CHEMISTRY, MEDICINAL
David C. Kombo,  and , Matthew J. LaMarche*, 
{"title":"化学优化的逻辑","authors":"David C. Kombo,&nbsp; and ,&nbsp;Matthew J. LaMarche*,&nbsp;","doi":"10.1021/acs.jmedchem.5c0044510.1021/acs.jmedchem.5c00445","DOIUrl":null,"url":null,"abstract":"<p >During multiparameter chemical optimization, molecular capabilities increase as hits evolve into leads and development candidates. Like retrosynthetic analysis, where target molecules are transformed into structurally simplified starting materials, we introduce retro-optimization analysis, transforming sophisticated development candidates into less capable leads and hits. To retrospectively understand the logic of optimization in discovery campaigns, we enumerated a matched molecular pair network and compared the actual route of optimization taken to alternative theoretical routes of optimization. We noted differences in the network and properties of the lead molecule compared to those of alternatives. We identified substructures of the evolving ligand, named “optimizons,” and tracked their emphasis and discovery. While we initially defined and illustrated these methods for a single project, our expansion to three additional discovery projects and three external data sets proved consistent. We retrospectively define the logic of optimization at the project, molecular, and submolecular levels to prospectively guide current and future optimization campaigns.</p>","PeriodicalId":46,"journal":{"name":"Journal of Medicinal Chemistry","volume":"68 11","pages":"11572–11585 11572–11585"},"PeriodicalIF":6.8000,"publicationDate":"2025-05-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The Logic of Chemical Optimization\",\"authors\":\"David C. Kombo,&nbsp; and ,&nbsp;Matthew J. LaMarche*,&nbsp;\",\"doi\":\"10.1021/acs.jmedchem.5c0044510.1021/acs.jmedchem.5c00445\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p >During multiparameter chemical optimization, molecular capabilities increase as hits evolve into leads and development candidates. Like retrosynthetic analysis, where target molecules are transformed into structurally simplified starting materials, we introduce retro-optimization analysis, transforming sophisticated development candidates into less capable leads and hits. To retrospectively understand the logic of optimization in discovery campaigns, we enumerated a matched molecular pair network and compared the actual route of optimization taken to alternative theoretical routes of optimization. We noted differences in the network and properties of the lead molecule compared to those of alternatives. We identified substructures of the evolving ligand, named “optimizons,” and tracked their emphasis and discovery. While we initially defined and illustrated these methods for a single project, our expansion to three additional discovery projects and three external data sets proved consistent. We retrospectively define the logic of optimization at the project, molecular, and submolecular levels to prospectively guide current and future optimization campaigns.</p>\",\"PeriodicalId\":46,\"journal\":{\"name\":\"Journal of Medicinal Chemistry\",\"volume\":\"68 11\",\"pages\":\"11572–11585 11572–11585\"},\"PeriodicalIF\":6.8000,\"publicationDate\":\"2025-05-26\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Medicinal Chemistry\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://pubs.acs.org/doi/10.1021/acs.jmedchem.5c00445\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CHEMISTRY, MEDICINAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Medicinal Chemistry","FirstCategoryId":"3","ListUrlMain":"https://pubs.acs.org/doi/10.1021/acs.jmedchem.5c00445","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0

摘要

在多参数化学优化过程中,随着热门产品演变为先导产品和开发候选产品,分子能力也随之提高。就像将目标分子转化为结构简化的起始材料的逆向合成分析一样,我们引入了逆向优化分析,将复杂的开发候选物转化为能力较差的先导物和hit。为了回顾性地理解发现活动中的优化逻辑,我们列举了一个匹配的分子对网络,并将实际的优化路径与备选的理论优化路径进行了比较。我们注意到与替代品相比,铅分子的网络和性质存在差异。我们确定了进化配体的亚结构,命名为“优化”,并跟踪了它们的重点和发现。虽然我们最初为单个项目定义和说明了这些方法,但我们扩展到三个额外的发现项目和三个外部数据集证明是一致的。我们回顾性地定义了项目、分子和亚分子水平的优化逻辑,以前瞻性地指导当前和未来的优化活动。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

The Logic of Chemical Optimization

The Logic of Chemical Optimization

During multiparameter chemical optimization, molecular capabilities increase as hits evolve into leads and development candidates. Like retrosynthetic analysis, where target molecules are transformed into structurally simplified starting materials, we introduce retro-optimization analysis, transforming sophisticated development candidates into less capable leads and hits. To retrospectively understand the logic of optimization in discovery campaigns, we enumerated a matched molecular pair network and compared the actual route of optimization taken to alternative theoretical routes of optimization. We noted differences in the network and properties of the lead molecule compared to those of alternatives. We identified substructures of the evolving ligand, named “optimizons,” and tracked their emphasis and discovery. While we initially defined and illustrated these methods for a single project, our expansion to three additional discovery projects and three external data sets proved consistent. We retrospectively define the logic of optimization at the project, molecular, and submolecular levels to prospectively guide current and future optimization campaigns.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Journal of Medicinal Chemistry
Journal of Medicinal Chemistry 医学-医药化学
CiteScore
4.00
自引率
11.00%
发文量
804
审稿时长
1.9 months
期刊介绍: The Journal of Medicinal Chemistry is a prestigious biweekly peer-reviewed publication that focuses on the multifaceted field of medicinal chemistry. Since its inception in 1959 as the Journal of Medicinal and Pharmaceutical Chemistry, it has evolved to become a cornerstone in the dissemination of research findings related to the design, synthesis, and development of therapeutic agents. The Journal of Medicinal Chemistry is recognized for its significant impact in the scientific community, as evidenced by its 2022 impact factor of 7.3. This metric reflects the journal's influence and the importance of its content in shaping the future of drug discovery and development. The journal serves as a vital resource for chemists, pharmacologists, and other researchers interested in the molecular mechanisms of drug action and the optimization of therapeutic compounds.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信